10 Strong Buy Small Cap Stocks to Invest In
In this article, we will take a look at 10 Strong Buy Small Cap Stocks to Invest In.
Mineralys Therapeutics Inc. (MLYS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Laurion Capital Management Benjamin A. Smith | 2,481,698 | $62,365,071 | -1% | 1% |
| 2. | Bayforest Capital Theodoros Tsagaris | 2,196 | $55,185 | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.16 | 58,300 | $1,408,528.00 | 5,825,521 | 2026-03-30 | Filing | |
| $23.67 | 310,700 | $7,354,269.00 | 5,767,221 | 2026-03-27 | Filing | |
| $25.50 | 588,235 | $14,999,992.50 | 588,235 | 2025-09-04 | Filing | |
| $25.50 | 1,176,470 | $29,999,985.00 | 5,456,521 | 2025-09-04 | Filing | |
| $13.50 | 259,259 | $3,499,996.50 | 8,903,838 | 2025-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.46 | 75,000 | $1,909,665.00 | 528,621 | 2026-09-30 | Filing | |
| $28.81 | 104,320 | $3,005,302.72 | 7,805,718 | 2026-09-22 | Filing | |
| $28.12 | 7,438 | $209,135.73 | 38,400 | 2026-09-21 | Filing | |
| $28.58 | 3,000 | $85,740.00 | 6,200 | 2026-09-15 | Filing | |
| $25.98 | 7,437 | $193,188.72 | 38,400 | 2026-08-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,799,518 | $196,001,887 | 93.45% | |
| 2. | 1,684,708 | $42,345,039 | 0% | |
| 3. | 1,591,917 | $40,004,874 | 22.77% | |
| 4. | 1,376,686 | $34,596,119 | 0.03% | |
| 5. | 729,902 | $18,409,454 | 0.08% |
News See All
Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential?
We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. Mineralys Therapeutics, Inc. (NASDAQ:MLYS) is one of the best up and coming stocks on our list.
8 Hidden Multibagger Stocks to Buy Now
In this article, we will look at the 8 Hidden Multibagger Stocks to Buy Now.
8 Best Up and Coming Pharmaceutical Stocks to Buy Now
In this article, we will be taking a look at the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now.
11 Best Young Stocks to Invest In According to Hedge Funds
In this article, we will discuss the 11 Best Young Stocks to Invest In According to Hedge Funds.
10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript May 6, 2026Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.51.
Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now?
Is MLYS a good stock to buy? We came across a bullish thesis on Mineralys Therapeutics, Inc. on Valueinvestorsclub.com by conway968. In this article, we will summarize the bulls’ thesis on MLYS.
10 Best New Stocks to Invest In According to Hedge Funds
In this article, we will discuss the 10 Best New Stocks to Invest In According to Hedge Funds.
7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
Hedge Fund Resource Center